
|Articles|July 24, 2019
Versiti Acquires Cenetron Central Laboratories and Salus IRB
Advertisement
Versiti has announced the acquisition of Texas-based Cenetron Central Laboratories, and its subsidiary, Salus IRB. The acquisition will not impact Cenetron’s 40 employees, and the laboratory will maintain its name and current location in Austin.
For more details, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
FDA Issues Draft Guidance to Advance Bayesian Methods in Clinical Trials
3
Breaking Out of AI Pilot Mode in Clinical Development
4
ACT Brief: Community Sites Prove Readiness, Platformization Reshapes Clinical Ops, and AI Targets Precision Care at JPM
5



